Treatments for Eosinophilic granulomatosis with polyangiitis

FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.

ℹ
Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.
Report missing data

FDA-approved treatments (2)

Patient support programs (1)

Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.

Fasenra

AstraZeneca Pharmaceuticals LP

Fasenra Patient Support (AZ&Me)

Patient Assistance
Manufacturer Program
Accepting applications
Apply

More about Eosinophilic granulomatosis with polyangiitis